Clene Inc. (NASDAQ:CLNN) Given Consensus Recommendation of "

Clene Inc. (NASDAQ:CLNN – Get Free Report) has received a consensus rating of “Buy” from the six research firms that are covering the stock, Marketbeat.com reports. Six investment analysts have rated the stock with a buy rating. The average 12 month target price among brokers that have covered the stock in the last year is […]

Related Keywords

Davidj Matlin , , Millennium Management , Investment Company Inc , Silverarc Capital Management , Worth Venture Partners , Nasdaq , Clene Inc , Get Free Report , Director David , Venture Partners , Bay Capital Management , Capital Management , Trading Down , Get Free , Multiple Sclerosis , Clene Daily , Clene , Nasdaq Clnn , Clnn , Medical , Ratings , Consensus ,